-- phpMyAdmin SQL Dump
-- version 5.0.1
-- https://www.phpmyadmin.net/
--
-- Host: 127.0.0.1
-- Generation Time: Apr 12, 2020 at 03:07 PM
-- Server version: 10.4.11-MariaDB
-- PHP Version: 7.4.1

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET AUTOCOMMIT = 0;
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `foodborne_disease`
--

-- --------------------------------------------------------

--
-- Table structure for table `admin_login`
--

CREATE TABLE `admin_login` (
  `admin_id` int(11) NOT NULL,
  `admin_email` varchar(100) NOT NULL,
  `admin_password` varchar(100) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `admin_login`
--

INSERT INTO `admin_login` (`admin_id`, `admin_email`, `admin_password`) VALUES
(1, 'vishwakarmaryan143@gmail.com', '123');

-- --------------------------------------------------------

--
-- Table structure for table `comment_table`
--

CREATE TABLE `comment_table` (
  `comment_id` int(11) NOT NULL,
  `comment_name` varchar(10000) NOT NULL,
  `comment` text NOT NULL,
  `cur_date` date NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

-- --------------------------------------------------------

--
-- Table structure for table `disease_caused`
--

CREATE TABLE `disease_caused` (
  `id` int(11) NOT NULL,
  `name` varchar(40) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `disease_caused`
--

INSERT INTO `disease_caused` (`id`, `name`) VALUES
(1, 'Fungal'),
(2, 'Bacterial'),
(3, 'Virus'),
(4, 'Protozoa'),
(5, 'Air Pollution'),
(6, 'Water Pollution');

-- --------------------------------------------------------

--
-- Table structure for table `disease_data`
--

CREATE TABLE `disease_data` (
  `id` int(11) NOT NULL,
  `disease_id` int(11) NOT NULL,
  `disease_title` mediumtext NOT NULL,
  `disease_content` longtext NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `disease_data`
--

INSERT INTO `disease_data` (`id`, `disease_id`, `disease_title`, `disease_content`) VALUES
(1, 2, 'Aeromonas hydrphila', '<style>\r\n	.data_insertion{\r\n		font-size: 16px;\r\n	}\r\n	.name{\r\n		font-weight: bolder;\r\n		font-size: 20px;\r\n		color: #8A4D6A;\r\n	}\r\n	.bold_action{\r\n		font-weight: bolder;\r\n		color: #1F283D;\r\n		font-size: 20px;\r\n	}\r\n	.Classification_heading{\r\n		font-weight: bolder;\r\n	}\r\n	.Taxonomic{\r\n		text-align: center;\r\n	}\r\n	table, th, td {\r\n		border: 1px solid black;\r\n		border-collapse: collapse;\r\n	}\r\n	th, td {\r\n		padding: 5px;\r\n		text-align: center;    \r\n	}\r\n</style>\r\n\r\n<div class=\"data_insertion\">\r\n	<span>\r\n		<span class=\"name\">Organism Name:-</span> <span>Aeromonas hydrphila</span>\r\n	</span>\r\n	<br>\r\n	<br>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Disease Caused</span>\r\n		<ul>\r\n			<li>Gastroenteritis and Skin Infections</li>\r\n			<li>Peritonitis</li>\r\n			<li>Bacteremia</li>\r\n			<li>Meningitis</li>\r\n			<li>Cholera-like Illness</li>\r\n			<li>Hemolytic Uremic Syndrome</li>\r\n			<li>Necrotizing Fasciitis</li>\r\n			<li>Motile aeromonad septicemia in carp, tilapia, perch, catfish, and salmon</li>\r\n			<li>Red Sore Disease in bass and carp</li>\r\n			<li>Ulcerative infections like epizootic ulcerative syndrome in catfish, cod, carp, and goby</li>\r\n		</ul>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Found In</span>\r\n		\r\n		<ul>\r\n			<li>Contaminated Water</li>\r\n			<li>Food Like Meat</li>\r\n			<li>Dairy</li>\r\n			<li>Shrimp OR Fish </li>\r\n		</ul>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">General Description</span>\r\n		<p>Gram-negative, rod-shaped facultative anaerobes, ranging in size from 0.3-1.0 µm wide by 1.0-3.5 µm long. They are motile by a single polar flagellum. The bacteria can produce heat-labile enterotoxins, which can be associated with haemolysin and cytotoxin production.</p>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Hosts</span>\r\n		<ul>\r\n			<li>Human</li>\r\n			<li>Animals</li>\r\n			<li>Birds</li>\r\n			<li>Fish</li>\r\n			<li>Cold-Blooded Marine and Fresh-water Reptiles</li>\r\n		</ul>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Transmission</span>\r\n		<p>Infection is spread via fecal-oral transmission during direct ingestion or drinking of contaminated water or foods. Infection can also be transmitted by eating contaminated meat, dairy, shrimp, or fish. It can be transferred from human-to-human by contact with infected wounds, feces or blood. The pathogen can also be transferred during sports; especially when played in muddy environments involving transfer of infected soil.</p>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Affected Organ:-</span><span>Gastro Intestinal Organs</span>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Hosts</span>\r\n		<ul>\r\n			<li>Rice- Water Diarrhea</li>\r\n			<li>Mild Symptoms include Fever and Chills</li>\r\n			<li>Overwhelming Bacterial Infection often exhibit abdominal pain, nausea, vomiting, and diarrhea</li>\r\n			<li>Dysenteric gastroenteritis that causes loose stools filled with blood and mucus</li>\r\n		</ul>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Inclubation Period</span>\r\n		<p>The reported incubation period for Aeromonas-associated diarrhea is 1 to 2 days. Aeromonas’ infections contracted via recreational sporting activities, such as swimming occur as early as 24h post exposure. Cellulitis is the most frequent soft tissue infection and is usually accompanied by systemic signs developing within 8 to 48 h. The length of time from initial A. hydrophila infection to bacteremia ranges from 1 to 38 days.</p>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Pervention</span>\r\n		<p>limit the Aeromonas species entering the distribution system through effective treatment and maintenance, to maintain temperatures below 14°C, to provide free-chlorine residuals above 0.1–0.2?mg/L, and to limit the levels of organic carbon compounds in the water.</p>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Susceptible</span>\r\n		<ul>\r\n			<li>Cefotaxime</li>\r\n			<li>Ciprofloxacin</li>\r\n			<li>Nalidixic acid and Silver</li>\r\n			<li>Chlorine in water</li>\r\n		</ul>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<div>\r\n		<span class=\"bold_action\">Taxonomic Classification</span>\r\n		<br>\r\n		<table style=\"width:30%\">\r\n		<br>\r\n			<tr>\r\n				<th colspan=\"2\" style=\"text-align: center;\">Classification</th>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Domain</td>\r\n				<td>Bacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Kingdom</td>\r\n				<td>Proteobacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Phylum</td>\r\n				<td>Gammaproteobacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Class</td>\r\n				<td>Aeromonadales</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Genus</td>\r\n				<td>Aeromonas</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Species</td>\r\n				<td>A. Hydrophila</td>\r\n			</tr>		\r\n		</table>\r\n	</div>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Genome Information</span>\r\n		<p>Aeromonas hydrophila subsp. hydrophila ATCC 7966, Ref Seq: NC_008570.1, DNA circular, Size 4.74Mb, GC% 61.5, Protein 4119, rRNA 31, tRNA 128, Gene 4,284</p>\r\n	</span>\r\n	<hr align=\"right\" width=\"auto\">\r\n	<span>\r\n		<span class=\"bold_action\">Reference</span>\r\n		<ul>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601520/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601520</a></li>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373137/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373137</a></li>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097544/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097544</a></li>\r\n			<li><a href=\"https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/aeromonas-hydrophila.html\">https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/aeromonas-hydrophila</a></li>\r\n			<li><a href=\"http://antimicrobe.org/b74.asp\">http://antimicrobe.org/b74</a></li>\r\n			<li><a href=\"https://wwwnc.cdc.gov/eid/article/9/5/02-0451_article\">https://wwwnc.cdc.gov/eid/article/9/5/02-0451_article</a></li>\r\n			<li><a href=\"https://www.msdsonline.com/resources/sds-resources/free-safety-data-sheet-index/aeromonas-hydrophila/\">https://www.msdsonline.com/resources/sds-resources/free-safety-data-sheet-index/aeromonas-hydrophila</a></li>\r\n			<li><a href=\"https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/aeromonas-hydrophila\">https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/aeromonas-hydrophila</a></li>\r\n			<li><a href=\"https://www.academia.edu/Documents/in/Aeromonas_Hydrophila\">https://www.academia.edu/Documents/in/Aeromonas_Hydrophila</a></li>\r\n		</ul>\r\n	</span>\r\n</div>'),
(2, 1, 'Rhizopus', '<style>\r\n	.data_insertion{\r\n		font-size: 16px;\r\n	}\r\n	.name{\r\n		font-weight: bolder;\r\n		font-size: 20px;\r\n		color: #8A4D6A;\r\n	}\r\n	.bold_action{\r\n		font-weight: bolder;\r\n		color: #1F283D;\r\n		font-size: 20px;\r\n	}\r\n	.Classification_heading{\r\n		font-weight: bolder;\r\n	}\r\n	.Taxonomic{\r\n		text-align: center;\r\n	}\r\n	table, th, td {\r\n		border: 1px solid black;\r\n		border-collapse: collapse;\r\n	}\r\n	th, td {\r\n		padding: 5px;\r\n		text-align: center;    \r\n	}\r\n</style>\r\n\r\n<div class=\"data_insertion\">\r\n	<span>\r\n		<span class=\"name\">Organism Name:-</span> <span>Rhizopus</span>\r\n	</span>\r\n	<br>\r\n	<br>\r\n	<span>\r\n		<span class=\"bold_action\">General Description</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Rhizopus is a type of fungus which belongs to the class Zygomycetes because of the fact that it produces zygospore in its sexual reproductive phase. It also refers to bread, black or pin mould. These can reproduce by vegetative, asexual and sexual means followed by fragmentation, sporangiospores and zygospores. Rhizopus is cosmopolitan in distribution. It grows on a variety of substrates like fruits, vegetables, bread, jellies etc. There are around 8-10 known species of Rhizopus. The name Rhizopus was first named by Ehrenb in 1820.</p>\r\n	</span>\r\n	<div>\r\n		<span class=\"bold_action\">Taxonomic Classification</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<table style=\"width:30%\">\r\n			<tr>\r\n				<th colspan=\"2\" style=\"text-align: center;\">Classification</th>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Kingdom</td>\r\n				<td>Fungi</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Division</td>\r\n				<td>Mycota</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Sub-Division</td>\r\n				<td>Eumycotina</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Class</td>\r\n				<td>Zygomycetes</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Order</td>\r\n				<td>Mucorales</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Family</td>\r\n				<td>Mucoraceae</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Genus</td>\r\n				<td>Rhizopus</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Species</td>\r\n				<td>Rhizopus oryzae</td>\r\n				<tr><td></td><td>Rhizopus microsporus</td></tr>\r\n				<tr><td></td><td>Rhizopus azygosporus</td></tr>\r\n				<tr><td></td><td>Rhizopus schipperae</td></tr>\r\n			</tr>		\r\n		</table>\r\n	</div>\r\n	<br>	\r\n	<span>\r\n		<span class=\"bold_action\">Species</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>There are several species in the genus Rhizopus.The most common ones are :- </p>\r\n		<ul class=\"species\">\r\n			<li>Rhizopus arrhizus</li>\r\n			<li>Rhizopus azygosporus</li>\r\n			<li>Rhizopus microsporus</li>\r\n			<li>Rhizopus schipperae</li>\r\n			<li>Rhizopus stolonifer</li>\r\n			<p>Some morphological features, such as the length of rhizoids and sporangiophores, the diameter of sporangia, the shape of columellae, and the size, shape and surface texture of sporangiospores aid in differentiation of Rhizopus species from each other. Maximum growth temperature also varies from one species to other <a href=\"#1\">[1]</a>.</p>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Pathogenicity and Clinical Significance</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Rhizopus spp. are among the fungi causing the group of infections referred to as zygomycosis. Although the term mucormycosis has often been used for this syndrome, zygomycosis is now the preferred term for this angio-invasive disease.</li>\r\n			<li>Rhizopus arrhizus is the most common cause of zygo-mycosis <a href=\"#2\">[2]</a> and is followed by Rhizopus microsporus var. rhizopodiformis.</li>\r\n			<li>Zygomycosis includes mucocutaneous, rhinocerebral, genitourinary, gastrointestinal, pulmonary, and disseminated infections.</li>\r\n			<li>Diabetic ketoacidosis and immunosuppression due to various reasons, such as organ transplanta-tion are the most frequent predisposing factors [<a href=\"#2\">2</a><a href=\"#3\">, 3</a><a href=\"#4\">, 4</a> and <a href=\"#5\">5</a>]</li>\r\n			<li>Desferoxamine treatment, renal failure, extensive burns, trauma, and intravenous drug use may also predispose to development of zygomycosis [<a href=\"#6\">6</a>].</li>\r\n			<li>While heatstroke has been described as a risk factor for disseminated zygomycosis [<a href=\"#7\">7</a>], contam-inated adhesive tapes and wooden tongue depressors have been reported to lead to nosocomial outbreaks of zygomycosis [<a href=\"#8\">8</a>]</li>\r\n			<li>Vascular invasion that causes necrosis of the infected tissue, and perineural invasion are the most frustrating features of these infections [<a href=\"#9\">9</a>]. Zygomycosis is frequently fatal.</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Epidemiology</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>A few members of the Mucorales are able to grow in human tissues causing a wide spectrum of clinical diseases. The entity and severity of the disease depends on the interaction between the fungus and the host immune defences.</li>\r\n			<li>In their exhaustive review, Roden and coworkers analysed 929 cases of documented infections caused by members of the former Zygomycota since 1885. They found that 19% of patients did not have any underlying disease at time of infection, while diabetes (36% of cases) was the main risk factor for developing the infection among patients with underlying conditions.</li>\r\n			<li>More recently, 230 cases of infections were collected in 13 European countries between 2005 and 2007. The majority of patients (53%) had haematological malignancies (44%) and haematopoietic stem-cell transplantation (9%) as underlying conditions, while only 9% of patients presented diabe-tes mellitus as the main risk factor.</li>\r\n			<li>Rhizopus spp. are the most common causative agents of invasive mucormycosis, Mucor spp. and Lichteimia (formerly Absidia) spp. rank as second and/or third cause [<a href=\"#11\">11</a>–<a href=\"#12\">12</a>]. Although mu-cormycosis remains a highly fatal disease, its burden is still low, as well documented by Pagano and coworkers. They were able to demonstrate that mucormycosis affected about 0.1% of 11,802 patients with hematologic malignancies. Among the 346 cases of proven and probable mold infections, only 14 (4%) were caused by members of Mucorales [<a href=\"#10\">10</a>].</li>\r\n			<li>In immune-competent subjects, mucormycosis generally develops as a consequence of traumat-ic injuries, and the disease commonly involves skin even if possible dissemination from skin to con-tiguous organs can occur [<a href=\"#12\">12</a>, <a href=\"#13\">13</a>].</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Infections</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<p>Mucormycosis can be classified in rhinocerebral, pulmonary and disseminated, abdominal-pelvic and gastric, and cutaneous or chronic subcutaneous diseases. Common features of rhinocerebral, pulmonary, and disseminated diseases include blood vessel invasion, hemorrhagic necrosis, thrombosis, and a rapid fatal outcome.</p>\r\n			<p>Rhinocerebral mucormycosis is more often associated with uncontrolled diabetes mellitus and ke-toacidosis than malignancies or deferoxamine therapy. Inhaled spores colonize at first the upper turbinates and paranasal sinuses and cause sinusitis. Depending on the underlying disease, the fungus can rapidly invade the central nervous system, causing symptoms like an altered mental state, progression to coma, and death within a few days [<a href=\"#14\">14</a>, <a href=\"#15\">15</a>, <a href=\"#16\">16</a>, <a href=\"#13\">13</a>].</p>\r\n			<p>Pulmonary mucormycosis is commonly seen in patients with leukemia, lymphoma, solid organ or bone marrow transplantation, and diabetes but is occasionally reported also in apparently healthy subjects. Disease manifestations vary from a localized nodular lesion to cavitary lesions and dis-semination; in the latter case, massive hemoptysis generally occurs. Crude mortality is lower (60%) in cases of isolated lesions than in severe pulmonary (87%) and disseminated (95%) diseases [<a href=\"#12\">12</a>].\r\n			Gastrointestinal disease is a rare manifestation of mucormycosis, and it is mainly associated with malnutrition in presence of predisposing factors, especially in children with amoebic colitis, ty-phoid, and pellagra [<a href=\"#13\">13</a>]. In the most severe cases, the disease can be characterized by ulceration of the mucosa and invasion of blood vessels with subsequent production of necrotic ulcers, this form of the disease is fatal [<a href=\"#13\">13</a>, <a href=\"#15\">15</a>].</p>\r\n			<p>Cutaneous mucormycosis may be a primary disease following skin barrier break or may occur as a consequence of hematogenous dissemination from other sites, and the outcome of the disease is strictly dependent on the patients’ conditions. Primary cutaneous mucormycosis can involve the subcutaneous tissue as well as the fat, muscle and fascial layers.</p>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Treatment</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Liposomal amphotericin B is the drug of choice for the therapy of mucormycosis.</li>\r\n			<li>The in vitro susceptibility testing for amphotericin B gives a broad range of values according to the genus and the species. With the exception of posaconazole, the azole derivatives show a limited in vitro activity against Mucorales, and the echinocandins have a limited activity against these fungi [<a href=\"#17\">17</a>].</li>\r\n			<li>Studies of in vitro combination of posaconazole with amphotericin B showed synergistic effects against hyphae of some species.</li>\r\n			<li>In addition, combination therapy with liposomal amphotericin B plus caspofungin or posaconazole and posaconazole with colony-stimulating factor has been successfully used in experimental infec-tions [<a href=\"#18\">18</a>, <a href=\"#19\">19</a>, <a href=\"#20\">20</a>].</li>\r\n			<li>In humans, combination therapy (liposomal amphotericin B plus echinocandins or posaconazole with or without iron chelation) has been used as aggressive antifungal treatment following surgi-cal resection of the damaged tissue.</li>\r\n			<li>Patients treated with combination of antifungal drugs had a better survival outcome than those treated with amphotericin B alone[<a href=\"#21\">21</a>, <a href=\"#22\">22</a>]. </li>\r\n			<li>A promising therapeutic approach consists of the use of iron chelation. Although deferoxamine therapy is associated with a high risk to develop mucormycosis, newer iron chelators (deferiprone and deferasirox) have not been associated with increased risk of mu-cormycosis and have been used as therapeutic agents in cases of experimental mucormycosis[<a href=\"#23\">23</a>].</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Virulence Trait and Pathogenesis</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<p>According to Casadevall and Pirofski [<a href=\"#24\">24</a>]: “Quantitative and qualitative measures of virulence vary as a function of host factors, microbial factors, environmental factors, social factors and interac-tions amongst them”. This concept is especially true if we consider opportunistic microorganisms such as fungi. Macrophages and neutrophils play the major role in immune defence against agents of mucormycosis. Prolonged neutropenia is thus the main risk factor for developing the disease. Moreover, therapeutic interventions (i.e., corticosteroid therapy), that cause functional defects in macrophages and neutrophils, represent additional risk factors for mucormycosis. Diabetes itself can impair the function of neutrophils contributing to the severity of the mucormycosis in patients with ketoacidosis [<a href=\"#25\">25</a>]. An important protective factor against mucormycosis is the low concentra-tion of free iron in plasma and tissues. Many of the underlying diseases listed above as predispos-ing factors for developing mucormycosis share an iron overload as a consequence of iron tissue burden, elevated serum transferring, or increased nontransferrin-bound iron [<a href=\"#23\">23</a>]. Iron is essential for Mucorales either enhancing their growth and hyphal development in vitro or increasing their pathogenicity in vivo [<a href=\"#26\">26</a>]. Hemodialysis patients under treatment with deferoxamine (DFO), an iron chelator, are particularly at risk for mucormycosis, and Boelaert and coworkers reported a high mortality (89%) in 46 patients who developed severe mucormycosis during DFO treatment. The same group [<a href=\"#26\">26</a>, <a href=\"#27\">27</a>] was able to demonstrate that Mucorales use DFO as a xeno-siderophore, being capable to detach iron from DFO in a very efficient manner. More recently, other investiga-tors confirmed the importance of iron in the pathogenicity of Mucorales by studying the expres-sion of the FTR1 (high-affinity iron permease of R. oryzae) gene and its product [<a href=\"#28\">28</a>]. The authors were able to demonstrate the effect of gene disruption and gene silencing on R. oryzae, which was unable to acquire iron in vitro and showed a reduced virulence in mice. Consistently, anti-Ftr1p antibodies protected mice from R. oryzae infection [<a href=\"#28\">28</a>]. Angioinvasion with subsequent infarction of the surrounding tissue is uniformly present in all cases of severe disseminated mucormycosis [<a href=\"#29\">29</a>]. Specific adhesion to endothelial cells and internalization of the fungus by the endothelial cells are important for the pathogenic strategy of Mucorales [<a href=\"#30\">30</a>]. </p>\r\n\r\n			<p>More recently, Liu and coworkers [<a href=\"#31\">31</a>] demonstrated that a novel host receptor (the glucose-regulated protein 78 [GPR78]) facilitates the invasion of human endothelial cells by Rhizopus ory-zae. This study demonstrated that in the presence of high iron and glucose concentrations, such as in diabetic subjects, there is a direct relationship between an increased expression of GPR78 and an increased damage to endothelial cells in diabetic mice [<a href=\"#31\">31</a>]. Involvement of the CNS is common in invasive mucormycosis, Mucorales are capable to gain access to the central nervous system (CNS) by local vessels invasion or direct extension from paranasal sinuses. Another possible mechanism, involving a retrograde extension of the fungi into CNS by means of the nerves, was hypothesized by Frater and coworkers [<a href=\"#29\">29</a>]. By evaluating the histologic features of 20 patients with invasive disease, they found a high percentage of perineural invasion. A further fas-cinating hypothesis concerning the virulence of Mucorales, in particular of Rhizopus species—the most common etiological agents of disseminated mucormycosis—is a possible involvement of en-dosymbiotic bacteria in the pathogenesis of the disease [<a href=\"#32\">32</a>]. The authors formulate their hypothe-sis on the basis of the ability of Rhizopus species to live with endosymbiotic toxin-producing bacte-ria [<a href=\"#33\">33</a>] and of the existing link between emergence of mucormycosis and the increased drug re-sistance of Gram-negative bacteria seen in the recent decades. Later on, both the groups of re-searchers demonstrated that endosymbiotic toxin-producing bacteria were not essential for the pathogenesis of mucormycosis [<a href=\"#34\">34</a>, <a href=\"#35\">35</a>]. Other potential virulence factors of Mucorales could be proteolytic, lipolytic, and glycosidic enzymes as well as metabolites like alkaloids or mycotoxins as agroclavine. However, their direct involvement in human cases of mucormycosis has been still to be documented [<a href=\"#15\">15</a>].</p>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Diagnosis</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Histology and culture are still the most important diagnostic approaches for mucormycosis be-cause of the lacking of molecular diagnosis methods standardized or commercially available. Moreover the ?-1–3 glucan detection is not useful in this kind of infection due to the extremely low content of this molecule in the Mucorales [<a href=\"#36\"></a>, <a href=\"#37\">37</a>]. Timely diagnosis of invasive mucormycosis is essential due to the rapid progression of the disease, and because signs and symptoms of the infection could mimic other invasive fungal infections. </li>\r\n			<li>Tissue biopsies are the clinical specimens of choice and should be submitted to histopathological and microbiological examination. When cultures are performed, it should be remembered that slicing rather than grinding of the samples should be adopted, because grinding could result in the loss of viability due to the coenocytic characteristics of the mycelium. </li>\r\n			<li>Microscopic detection of aseptate or pauciseptate hyphae with a large diameter and wide branch-ing angles is suggestive of mucormycosis. Histopathological examination of the infected tissues reveals inflammatory response, often entirely filled with neutrophils, invasion of arterial and venous walls (angioinvasion) with subsequent infarction, and perineural invasion [<a href=\"#29\">29</a>].</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Reference</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ol>\r\n			<li id =\"1\">Larone, D. H. 1995. Medically Important Fungi – A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.</li>\r\n			<li id=\"2\">Chakrabarti, A., A. Das, A. Sharma, N. Panda, S. Das, K. L. Gupta, and V. Sakhuja. 2001. Ten years’ experience in zygomycosis at a tertiary care centre in India. J Infection. 42:261-266.</li>\r\n			<li id=\"3\">Eucker, J., O. Sezer, B. Graf, and K. Possinger. 2001. Mucormycoses. Mycoses. 44:253-260.</li>\r\n			<li id=\"4\">Grossi, P., C. Farina, R. Fiocchi, and D. Dalla Gasperina. 2000. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients – A multicenter retrospective study. Transplantation. 70:112-116.</li>\r\n			<li id=\"5\">Patel, R., D. Portela, A. D. Badley, W. S. Harmsen, J. J. Larson-Keller, D. M. Ilstrup, M. R. Keating, R. H. Wiesner, R. A. Krom, and C. V. Paya. 1996. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation. 62:926-934.</li>\r\n			<li id=\"6\">Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin Microbiol Rev. 13:236-301.</li>\r\n			<li id=\"7\">Anstead, G. M., D. A. Sutton, E. H. Thompson, I. Weitzman, R. A. Otto, and S. K. Ahuja. 1999. Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. J Clin Microbiol. 37:2656-2662.</li>\r\n			<li id=\"8\">Gartenberg, G., E. J. Bottone, G. T. Keusch, and I. Weitzman. 1978. Hospital-azquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: Epidemiogy, mycology, and treatment. N. Engl. J. Med. 299:1115-1118.</li>\r\n			<li id=\"9\">Frater, J. L., G. S. Hall, and G. W. Procop. 2001. Histologic features of zygomycosis – Emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 125:375-378.</li>\r\n			<li id=\"10\">L. Pagano, M. Caira, A. Candoni et al., “The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study,” Haematologica, vol. 91, no. 8, pp. 1068–1075, 2006.<a href=\"https://scholar.google.com/scholar_lookup?title=The+epidemiology+of+fungal+infections+in+patients+with+hematologic+malignancies%3A+the+SEIFEM-2004+study&author=L.+Pagano&author=M.+Caira&author=A.+Candoni+et+al.&publication_year=2006\">View at Google Scholar</a> . <a href=\"https://www.scopus.com/record/display.uri?eid=2-s2.0-33747055130&origin=inward&txGid=441cc74bdaffd597af717fe7621e3ee9\">View at Scopus Preview</a></li>\r\n			<li id=\"11\">M. Chayakulkeeree, M. A. Ghannoum, and J. R. Perfect, “Zygomycosis: the re-emerging fungal infection,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 25, no. 4, pp. 215–229, 2006. <a href=\"https://link.springer.com/article/10.1007%2Fs10096-006-0107-1\">View at Publisher</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16568297?dopt=AbstractPlus\">View at PubMed</a> . <a href=\"https://www.scopus.com/record/display.uri?eid=2-s2.0-33744477651&origin=inward&txGid=c5b9fa4151b95f4fbb4db335cafb8ed8\">View at Scopus</a> . 	<a href=\"https://scholar.google.com/scholar_lookup?title=Zygomycosis%3A+the+re-emerging+fungal+infection&author=M.+Chayakulkeeree&author=M.+A.+Ghannoum&author=J.+R.+Perfect&publication_year=2006\">View at Google Scholar </a></li>\r\n			<li id=\"12\">M. M. Roden, T. E. Zaoutis, W. L. Buchanan et al., “Epidemiology and outcome of zygomycosis: a review of 929 reported cases,” Clinical Infectious Diseases, vol. 41, no. 5, pp. 634–653, 2005. <a href=\"https://academic.oup.com/cid/article/41/5/634/327691\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Epidemiology+and+outcome+of+zygomycosis%3A+a+review+of+929+reported+cases&author=M.+M.+Roden&author=T.+E.+Zaoutis&author=W.+L.+Buchanan+et+al.&publication_year=2005\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16080086?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"13\">J. W. Rippon, “Zygomycosis,” in Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes, WB Saunders, Philadelphia, Pa, USA, 3rd edition, 1988. <a href=\"https://scholar.google.com/scholar_lookup?title=Zygomycosis&author=J.+W.+Rippon&publication_year=1988\">View at Google Scholar</a></li>\r\n			<li id=\"14\">G. S. De Hoog, J. Guarro, J. Genè, and M. J. Figueras, “Zygomycota,” in Atlas of Clinical Fungi, pp. 58–124, Centraalbureau voor Schimmelcultures, Universitat Rovira I Virgili, Utrecht, The Netherlands, 2000. <a href=\"https://scholar.google.com/scholar_lookup?title=Zygomycota&author=G.+S.+De+Hoog&author=J.++Guarro&author=J.+Gen%C3%A8&author=M.+J.+Figueras&publication_year=2000\">View at Google Scholar</a></li>\r\n			<li id=\"15\">J. A. Ribes, C. L. Vanover-Sams, and D. J. Baker, “Zygomycetes in human disease,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 236–301, 2000. <a href=\"https://cmr.asm.org/content/13/2/236\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Zygomycetes+in+human+disease&author=J.+A.+Ribes&author=C.+L.+Vanover-Sams&author=D.+J.+Baker&publication_year=2000\">View at Google Scholar</a></li>\r\n			<li id=\"16\">E. Mantadakis and G. Samonis, “Clinical presentation of zygomycosis,” Clinical Microbiology and Infection, vol. 15, no. 5, supplement, pp. 15–20, 2009. <a href=\"https://scholar.google.com/scholar_lookup?title=Clinical+presentation+of+zygomycosis&author=E.+Mantadakis&author=G.+Samonis&publication_year=2009\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19754751?dopt=AbstractPlus\">View at PubMed</a> . <a href=\"\"></a><a href=\"https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60722-9/fulltext\">View at Publisher</a></li>\r\n			<li id=\"17\">A. Alastruey-Izquierdo, M. V. Castelli, I. Cuesta et al., “In vitro activity of antifungals against zygomycetes,” Clinical Microbiology and Infection, vol. 15, no. 5, pp. 71–76, 2009. <a href=\"https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60733-3/fulltext\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=In+vitro+activity+of+antifungals+against+zygomycetes&author=A.+Alastruey-Izquierdo&author=M.+V.+Castelli&author=I.+Cuesta+et+al.&publication_year=2009\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19754762?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"18\">B. Spellberg, J. Edwards Jr., and A. Ibrahim, “Novel perspectives on mucormycosis: pathophysiology, presentation, and management,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 556–569, 2005. <a href=\"https://cmr.asm.org/content/18/3/556\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Novel+perspectives+on+mucormycosis%3A+pathophysiology%2C+presentation%2C+and+management&author=B.+Spellberg&author=J.+Edwards+Jr.&author=A.+Ibrahim&publication_year=2005\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16020690?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"19\">B. Spellberg, Y. Fu, J. E. Edwards Jr., and A. S. Ibrahim, “Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 2, pp. 830–832, 2005. <a href=\"https://aac.asm.org/content/49/2/830\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Combination+therapy+with+amphotericin+B+lipid+complex+and+caspofungin+acetate+of+disseminated+zygomycosis+in+diabetic+ketoacidotic+mice&author=B.+Spellberg&author=Y.+Fu&author=J.+E.+Edwards+Jr.&author=A.+S.+Ibrahim&publication_year=2005\">View at Google Scholar</a> . <a href=\"View at PubMed\">View at PubMed</a></li>\r\n			<li id=\"20\">N. Van Sickels, J. Hoffman, L. Stuke, and K. Kempe, “Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach,” Journal of Trauma, vol. 70, no. 2, pp. 507–509, 2011. <a href=\"https://insights.ovid.com/crossref?an=00005373-201102000-00039\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Survival+of+a+patient+with+trauma-induced+mucormycosis+using+an+aggressive+surgical+and+medical+approach&author=N.+Van+Sickels&author=J.+Hoffman&author=L.+Stuke&author=K.+Kempe&publication_year=2011\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21307754?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"21\">N. Van Sickels, J. Hoffman, L. Stuke, and K. Kempe, “Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach,” Journal of Trauma, vol. 70, no. 2, pp. 507–509, 2011. <a href=\"https://insights.ovid.com/crossref?an=00005373-201102000-00039\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Survival+of+a+patient+with+trauma-induced+mucormycosis+using+an+aggressive+surgical+and+medical+approach&author=N.+Van+Sickels&author=J.+Hoffman&author=L.+Stuke&author=K.+Kempe&publication_year=2011\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21307754?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"22\">J. Y. Ting, S. Y. Chan, D. C. Lung et al., “Intra-abdominal rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy,” Journal of Pediatric Hematology/Oncology, vol. 32, no. 6, pp. e238–e240, 2010. <a href=\"https://insights.ovid.com/crossref?an=00043426-201008000-00028\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Intra-abdominal+rhizopus+microsporus+infection+successfully+treated+by+combined+aggressive+surgical%2C+antifungal%2C+and+iron+chelating+therapy&author=J.+Y.+Ting&author=S.+Y.+Chan&author=D.+C.+Lung+et+al.&publication_year=2010\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20661158?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"23\">A. S. Symeonidis, “The role of iron and iron chelators in zygomycosis,” Clinical Microbiology and Infection, vol. 15, no. 5, supplement, pp. 26–32, 2009. <a href=\"https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60724-2/fulltext\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=The+role+of+iron+and+iron+chelators+in+zygomycosis&author=A.+S.+Symeonidis&publication_year=2009\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19754753?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"24\">A. Casadevall and L. A. Pirofski, “On virulence,” Virulence, vol. 1, no. 1, pp. 1–2, 2010. <a href=\"https://scholar.google.com/scholar_lookup?title=On+virulence&author=A.+Casadevall&author=L.+A.+Pirofski&publication_year=2010\">View at Google Scholar</a></li>\r\n			<li id=\"25\">R. Y. W. Chinn and R. D. Diamond, “Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis,” Infection and Immunity, vol. 38, no. 3, pp. 1123–1129, 1982. <a href=\"https://scholar.google.com/scholar_lookup?title=Generation+of+chemotactic+factors+by+Rhizopus+oryzae+in+the+presence+and+absence+of+serum%3A+relationship+to+hyphal+damage+mediated+by+human+neutrophils+and+effects+of+hyperglycemia+and+ketoacidosis&author=R.+Y.+W.+Chinn&author=R.+D.+Diamond&publication_year=1982\">View at Google Scholar</a></li>\r\n			<li id=\"26\">J. R. Boelaert, M. de Locht, J. Van Cutsem et al., “Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: in vitro and in vivo animal studies,” Journal of Clinical Investigation, vol. 91, no. 5, pp. 1979–1986, 1993. <a href=\"https://scholar.google.com/scholar_lookup?title=Mucormycosis+during+deferoxamine+therapy+is+a+siderophore-mediated+infection%3A+in+vitro+and+in+vivo+animal+studies&author=J.+R.+Boelaert&author=M.+de+Locht&author=J.+Van+Cutsem+et+al.&publication_year=1993\">View at Google Scholar</a></li>\r\n			<li id=\"27\">J. R. Boelaert, J. Van Cutsem, M. de Locht, Y. J. Schneider, and R. R. Crichton, “Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect,” Kidney International, vol. 45, no. 3, pp. 667–671, 1994. <a href=\"https://scholar.google.com/scholar_lookup?title=Deferoxamine+augments+growth+and+pathogenicity+of+Rhizopus%2C+while+hydroxypyridinone+chelators+have+no+effect&author=J.+R.+Boelaert&author=J.+Van+Cutsem&author=M.+de+Locht&author=Y.+J.+Schneider&author=R.+R.+Crichton&publication_year=1994\">View at Google Scholar</a></li>\r\n			<li id=\"28\">A. S. Ibrahim, T. Gebremariam, L. Lin et al., “The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis,” Molecular Microbiology, vol. 77, no. 3, pp. 587–604, 2010. <a href=\"https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2958.2010.07234.x\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=The+high+affinity+iron+permease+is+a+key+virulence+factor+required+for+Rhizopus+oryzae+pathogenesis&author=A.+S.+Ibrahim&author=T.+Gebremariam&author=L.+Lin+et+al.&publication_year=2010\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20545847?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"29\">J. L. Frater, G. S. Hall, and G. W. Procop, “Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology,” Archives of Pathology and Laboratory Medicine, vol. 125, no. 3, pp. 375–378, 2001. <a href=\"https://scholar.google.com/scholar_lookup?title=Histologic+features+of+zygomycosis%3A+emphasis+on+perineural+invasion+and+fungal+morphology&author=J.+L.+Frater&author=G.+S.+Hall&author=G.+W.+Procop&publication_year=2001\">View at Google Scholar</a></li>\r\n			<li id=\"30\">A. S. Ibrahim, B. Spellberg, V. Avanessian, Y. Fu, and J. E. Edwards, “Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro,” Infection and Immunity, vol. 73, no. 2, pp. 778–783, 2005.<a href=\"https://scholar.google.com/scholar_lookup?title=Rhizopus+oryzae+adheres+to%2C+is+phagocytosed+by%2C+and+damages+endothelial+cells+in+vitro&author=A.+S.+Ibrahim&author=B.+Spellberg&author=V.+Avanessian&author=Y.+Fu&author=J.+E.+Edwards&publication_year=2005\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/15664916?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"31\">M. Liu, B. Spellberg, Q. T. Phan et al., “The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 1914–1924, 2010. <a href=\"https://www.jci.org/articles/view/42164\">View at Publisher</a><a href=\"https://scholar.google.com/scholar_lookup?title=The+endothelial+cell+receptor+GRP78+is+required+for+mucormycosis+pathogenesis+in+diabetic+mice&author=M.+Liu&author=B.+Spellberg&author=Q.+T.+Phan+et+al.&publication_year=2010\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20484814?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"32\">G. Chamilos, R. E. Lewis, and D. P. Kontoyiannis, “Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: a hypothesis,” Fungal Genetics and Biology, vol. 44, no. 2, pp. 88–92, 2007. <a href=\"https://www.sciencedirect.com/science/article/pii/S1087184506001332?via%3Dihub\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Multidrug-resistant+endosymbiotic+bacteria+account+for+the+emergence+of+zygomycosis%3A+a+hypothesis&author=G.+Chamilos&author=R.+E.+Lewis&author=D.+P.+Kontoyiannis&publication_year=2007\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16990037?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"33\">L. P. Partida-Martinez and C. Hertweck, “Pathogenic fungus harbours endosymbiotic bacteria for toxin production,” Nature, vol. 437, no. 7060, pp. 884–888, 2005. <a href=\"https://www.nature.com/articles/nature03997\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Pathogenic+fungus+harbours+endosymbiotic+bacteria+for+toxin+production&author=L.+P.+Partida-Martinez&author=C.+Hertweck&publication_year=2005\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16208371?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"34\">A. S. Ibrahim, T. Gebremariam, M. Liu et al., “Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 1083–1090, 2008. <a href=\"https://academic.oup.com/jid/article/198/7/1083/2192000\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Bacterial+endosymbiosis+is+widely+present+among+zygomycetes+but+does+not+contribute+to+the+pathogenesis+of+mucormycosis&author=A.+S.+Ibrahim&author=T.+Gebremariam&author=M.+Liu+et+al.&publication_year=2008\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18694335?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"35\">L. P. Partida-Martinez, S. Bandemer, R. Rüchel, E. Dannaoui, and C. Hertweck, “Lack of evidence of endosymbiotic toxin-producing bacteria in clinical Rhizopus isolates,” Mycoses, vol. 51, no. 3, pp. 266–269, 2008. <a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1439-0507.2007.01477.x\">View at Publisher</a> . <a href=\"https://scholar.google.com/scholar_lookup?title=Lack+of+evidence+of+endosymbiotic+toxin-producing+bacteria+in+clinical+Rhizopus+isolates&author=L.+P.+Partida-Martinez&author=S.+Bandemer&author=R.+R%C3%BCchel&author=E.+Dannaoui&author=C.+Hertweck&publication_year=2008\">View at Google Scholar</a> . <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18399908?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"36\">Z. Odabasi, V. L. Paetznick, J. R. Rodriguez, E. Chen, M. R. McGinnis, and L. Ostrosky-Zeichner, “Differences in beta-glucan levels in culture supernatants of a variety of fungi,” Medical Mycology, vol. 44, no. 3, pp. 267–272, 2006. <a href=\"https://academic.oup.com/mmy/article/44/3/267/970020\">View at Publisher</a><a href=\"https://scholar.google.com/scholar_lookup?title=Differences+in+beta-glucan+levels+in+culture+supernatants+of+a+variety+of+fungi&author=Z.+Odabasi&author=V.+L.+Paetznick&author=J.+R.+Rodriguez&author=E.+Chen&author=M.+R.+McGinnis&author=L.+Ostrosky-Zeichner&publication_year=2006\">View at Google Scholar</a><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16702107?dopt=AbstractPlus\">View at PubMed</a></li>\r\n			<li id=\"37\">M. D. Richardson and P. Koukila-Kahkola, “Rhizopus, Rhizomucor, Absidia and other agents of systemic and subcutaneous zygomycoses,” in Manual of Clinical Microbiology, P. A. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller, Eds., pp. 1839–1856, ASM Press, Washington, DC, USA, 2007. <a href=\"https://scholar.google.com/scholar_lookup?title=Rhizopus%2C+Rhizomucor%2C+Absidia+and+other+agents+of+systemic+and+subcutaneous+zygomycoses&author=M.+D.+Richardson&author=P.+Koukila-Kahkola&publication_year=2007\">View at Google Scholar</a></li>\r\n		</ol>\r\n	</span>\r\n</div>');
INSERT INTO `disease_data` (`id`, `disease_id`, `disease_title`, `disease_content`) VALUES
(3, 2, 'Brucella Melitensis', '<style>\r\n	.data_insertion{\r\n		font-size: 16px;\r\n	}\r\n	.name{\r\n		font-weight: bolder;\r\n		font-size: 20px;\r\n		color: #8A4D6A;\r\n	}\r\n	.bold_action{\r\n		font-weight: bolder;\r\n		color: #1F283D;\r\n		font-size: 20px;\r\n	}\r\n	.Classification_heading{\r\n		font-weight: bolder;\r\n	}\r\n	.Taxonomic{\r\n		text-align: center;\r\n	}\r\n	table, th, td {\r\n		border: 1px solid black;\r\n		border-collapse: collapse;\r\n	}\r\n	th, td {\r\n		padding: 5px;\r\n		text-align: center;    \r\n	}\r\n</style>\r\n\r\n<div class=\"data_insertion\">\r\n	<span>\r\n		<span class=\"name\">Organism Name:-</span> <span>Brucella Melitensis</span>\r\n	</span>\r\n	<br>\r\n	<br>\r\n	<span>\r\n		<span class=\"bold_action\">Disease Caused</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n<p>Brucellosis zoonotic disease (any disease or infection that is naturally transmissible from vertebrate animals to humans and vice-versa is classified as a zoonotic disease).It is also known as “undulant fever”, “Mediterranean fever” or “Malta fever”.</p>\r\n	</span>\r\n\r\n	<span>\r\n		<span class=\"bold_action\">Found In</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Infected meat </li>\r\n			<li>Contaminated Water</li>\r\n			<li>unpasteurized dairy products</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">General Description</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Brucellae are Gram-negative coccobacilli (short rods) measuring about 0.6 to 1.5 ?m by 0.5-0.7 ?m. They are non-sporing and lack capsules or flagella and, therefore, are non-motile.The outer cell membrane closely resembles that of other Gram-negative bacilli with a dominant lipopolysaccharide (LPS) component and three main groups of proteins. The guanine-plus-cytosine content of the DNA is 55-58 moles/cm. Brucellae belong to ?–2 subdivision of proteobacteria. They are oxidase, catalase, nitrate reductase and urease positive. B. abortus preferentially infects cattle, B.melitensis sheep and goats, B. suis pigs and B. canis dogs. Above species infect humans with B.melitensis being the most common.</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Hosts</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Human</li>\r\n			<li>Sheep</li>\r\n			<li>Goat</li>\r\n			<li>Pigs</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Transmission</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Eating undercooked meat or consuming unpasteurized/raw dairy products. Bacteria can also enter wounds in the skin/mucous membranes through contact with infected animals. This poses a problem for workers who have close contact with animals or animal excretions (newborn animals, fetuses, and excretions that may result from birth).</li>\r\n			<li>Infected mothers who are breast-feeding may transmit the infection to their infants. Sexual transmission has been rarely reported.</li>\r\n			<li>While uncommon, transmission may also occur via tissue transplantation or blood transfusions. Breathing in the bacteria that causes brucellosis may also lead to infection.</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Affected Organ</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Head</li>\r\n			<li>Neck</li>\r\n			<li>Muscles</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Symptoms</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Brucellosis can cause of range of signs and symptoms, some of which may present for prolonged periods of time.Initial symptoms can include:-</p>\r\n		<ul>\r\n			<li>Fever</li>\r\n			<li>Wweats</li>\r\n			<li>Malaise</li>\r\n			<li>Anorexia</li>\r\n			<li>Headache</li>\r\n			<li>Pain in muscles, joint, and/or back</li>\r\n			<li>Fatigue</li>	\r\n		</ul>\r\n		<p>Some signs and symptoms may persist for longer periods of time. Others may never go away or reoccur. These can include:</p>\r\n		<ul>\r\n			<li>Recurrent Fevers</li>\r\n			<li>Arthritis</li>\r\n			<li>Swelling of the Testicle and Scrotum Area</li>\r\n			<li>Swelling of the Heart (Endocarditis)</li>\r\n			<li>Neurologic Symptoms (in up to 5% of all cases)</li>\r\n			<li>Chronic Fatigue</li>\r\n			<li>Depression</li>\r\n			<li>Swelling of the Liver and/or Spleen</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Inclubation Period</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>The incubation period after infection varies from 15 days to several months depending on the invasion site and the infecting dose. Therefore, it takes some time for signs of infection to occur.</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Diagnosis</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>The clinical picture is not specific therefore diagnosis needs to be supported by laboratory tests.</p>\r\n		<ol>\r\n			<li>Presumptive diagnosis</li>\r\n			<ul>\r\n				<li>Rose Bengal test (RBT) for screening.</li>\r\n				<li>Standard agglutination test (SAT).</li>\r\n			</ul>\r\n			<li>Confirmatory diagnosis</li>\r\n			<ul>\r\n				<li>Isolation of Brucella spp. from blood or other clinical specimen.</li>\r\n				<li>A presumptive laboratory diagnosis based on detection of agglutinating antibodies (RBT, SAT) combined with detection of non-agglutinating antibodies through:\r\n					<ul>\r\n						<li>ELISA IgG test</li>\r\n						<li>Coombs IgG.</li>\r\n					</ul>\r\n				</li>\r\n			</ul>\r\n		</ol>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Pervention</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Human exposure can be reduced by controlling brucellosis in livestock. Pasteurization is recommended to destroy B. melitensis in milk products. The fermentation time necessary to ensure safety in ripened, fermented cheeses made from unpasteurized milk in unknown, but it has been estimated to be approximately 3 months. The World Health Organization (WHO) recommends storing soft cheeses > 6 months if they were made from unpasteurized milk. Meat, blood and internal organs from animals should be handled carefully and cooked thoroughly. Good hygiene, together with personal protective equipment (gloves, face/ eye protection, protective clothing and respirators, as appropriate) can decrease human exposure when handling infected animals. Wounds should be covered. Particular care should be taken when animals are giving birth or aborting, or when large numbers of animals are shedding organisms in a concentrated area.</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Treatment</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Brucellosis is usually treated with a prolonged course of antibiotics, combining two or more drugs for part or all of the treatment course.</li>\r\n			<li>Monotherapy is reported to have a high relapse rate.</li>\r\n			<li>Different antibiotics may be recommended, depending on the patient’s age, pregnancy status and syndrome.</li>\r\n		</ul>\r\n	</span>\r\n	<div>\r\n		<span class=\"bold_action\">Taxonomic Classification</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<table style=\"width:30%\">\r\n			<br>\r\n			<tr>\r\n				<th colspan=\"2\" style=\"text-align: center;\">Classification</th>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Kingdom</td>\r\n				<td>Bacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Phylum</td>\r\n				<td>Ptoteobacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Class</td>\r\n				<td>Alphaproteobacteria</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Order</td>\r\n				<td>Rhizobiales</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Family</td>\r\n				<td>Brucellaceae</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Genus</td>\r\n				<td>Brucella</td>\r\n			</tr>\r\n			<tr>\r\n				<td class=\"Classification_heading\">Species</td>\r\n				<td>Melitensis</td>\r\n			</tr>		\r\n		</table>\r\n	</div>\r\n	<br>\r\n	<span>\r\n		<span class=\"bold_action\">Genome Information</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p class=\"bold_action\">Environment:-\r\n			<ul>\r\n				<li>OxygenReq:Aerobic</li>\r\n				<li>OptimumTemperature:37</li>\r\n				<li>TemperatureRange:Mesophilic</li>\r\n				<li>Habitat:HostAssociated</li>\r\n			</ul>\r\n			<p class=\"bold_action\">Phenotype:</p>\r\n			<ul>\r\n				<li>Disease:Brucellosis</li>\r\n			</ul>\r\n			<table>\r\n				<tr>\r\n					<th>Type</th>\r\n					<th>Name</th>\r\n					<th>RefSeq</th>\r\n					<th>INSDC</th>\r\n					<th>Size (Mb)</th>\r\n					<th>GC %</th>\r\n					<th>Protein</th>\r\n					<th>rRNA</th>\r\n					<th>tRNA</th>\r\n					<th>Other RNA</th>\r\n					<th>Gene</th>\r\n					<th>Pseudogene</th>\r\n				</tr>\r\n				<tr>\r\n					<td>Chr</td>\r\n					<td>I</td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/NC_003317.1\">NC_003317.1</a></td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/AE008917.1\">AE008917.1</a></td>\r\n					<td>2.12</td>\r\n					<td>57.2</td>\r\n					<td>2,032</td>\r\n					<td>6</td>\r\n					<td>40</td>\r\n					<td>4</td>\r\n					<td>2,197</td>\r\n					<td>115</td>\r\n				</tr>\r\n				<tr>\r\n					<td>Chr</td>\r\n					<td>II</td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/NC_003318.1\">NC_003318.1</a></td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/AE008918.1\">AE008918.1</a></td>\r\n					<td>1.18</td>\r\n					<td>57.3</td>\r\n					<td>1,067</td>\r\n					<td>3</td>\r\n					<td>14</td>\r\n					<td>-</td>\r\n					<td>1,172</td>\r\n					<td>88</td>\r\n				</tr>\r\n			</table>\r\n		</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Reference</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li><a href=\"https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/brucella-melitensis\">https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/brucella-melitensis</a></li>\r\n			<li><a href=\"https://www.cabi.org/isc/datasheet/90734\">https://www.cabi.org/isc/datasheet/90734</a></li>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK8572/\">https://www.ncbi.nlm.nih.gov/books/NBK8572/</a></li>\r\n			<li><a href=\"http://brucellamelitensis.com/\">http://brucellamelitensis.com/</a></li>\r\n			<li><a href=\"http://brucellamelitensis.com/\">http://brucellamelitensis.com/</a></li>\r\n			<li><a href=\"https://www.cdc.gov/brucellosis/index.html\">https://www.cdc.gov/brucellosis/index.html</a></li>\r\n			<li><a href=\"http://www.cfsph.iastate.edu/Factsheets/pdfs/brucellosis_melitensis.pdf\">http://www.cfsph.iastate.edu/Factsheets/pdfs/brucellosis_melitensis.pdf</a></li>\r\n			<li><a href=\"https://www.academia.edu/Documents/in/Brucella_melitensis\">https://www.academia.edu/Documents/in/Brucella_melitensis</a></li>\r\n			<li><a href=\"https://www.ias.ac.in/article/fulltext/jbsc/033/04/0539-0547\">https://www.ias.ac.in/article/fulltext/jbsc/033/04/0539-0547</a></li>\r\n			<li><a href=\"https://www.nhp.gov.in/disease/brucellosis\">https://www.nhp.gov.in/disease/brucellosis</a></li>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989840/\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989840/</a></li>\r\n			<li><a href=\"https://www.ncbi.nlm.nih.gov/genome/?term=Brucella+melitensis\">https://www.ncbi.nlm.nih.gov/genome/?term=Brucella+melitensis</a></li>\r\n		</ul>\r\n	</span>\r\n</div>'),
(4, 2, 'Clostridium botulinum', '<style>\r\n	.data_insertion{\r\n		font-size: 16px;\r\n	}\r\n	.name{\r\n		font-weight: bolder;\r\n		font-size: 20px;\r\n		color: #8A4D6A;\r\n	}\r\n	.bold_action{\r\n		font-weight: bolder;\r\n		color: #1F283D;\r\n		font-size: 20px;\r\n	}\r\n	.Classification_heading{\r\n		font-weight: bolder;\r\n	}\r\n	.Taxonomic{\r\n		text-align: center;\r\n	}\r\n	table, th, td {\r\n		border: 1px solid black;\r\n		border-collapse: collapse;\r\n	}\r\n	th, td {\r\n		padding: 5px;\r\n		text-align: center;    \r\n	}\r\n	.mor{\r\n		margin-top: 8px;\r\n	}\r\n	.mor>li{\r\n		margin-top: 5px;\r\n	}\r\n	.refer{\r\n		font-size: 17px;\r\n	}\r\n	.sanger{\r\n		font-weight: 100;\r\n		font-size: small;\r\n	}\r\n</style>\r\n\r\n<div class=\"data_insertion\">\r\n	<span>\r\n		<span class=\"name\">Organism Name:-</span> <span>Clostridium botulinum</span>\r\n	</span>\r\n	<br>\r\n	<br>\r\n	<span>\r\n		<span class=\"bold_action\">General Description</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Clostridium botulinum are rod-shaped bacteria (also called C. botulinum. They are anaerobic, meaning they live and grow in low oxygen conditions. The bacteria form protective spores when conditions for survival are poor. C. botulinum spores are often found on the surfaces of fruits and vegetables and in seafood. C. botulinum is responsible for a disease called botulism.</p>\r\n		<p>Botulism is caused by a group of anaerobic spore-forming organisms called Clostridium botulinum. This is classified as a single species but consists of at least three genetically distinguishable groups of organisms that have been recognized as toxic for humans. They share the ability to produce neurotoxins with similar pharmacological activities but diverse serologic properties. The toxin types are classified as A, B, C, D, E, F and G. Human botulism has been described with the strains of Clostridium botulinum that produce toxin types A, B and E. Less frequently, cases involving type F toxin produced by C. baratii and type E toxin produced by C. butyricum have been published.</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Disease Caused</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Clostridium botulinum is responsible for a disease called botulism. Botulism is characterised by symmetrical, descending, flaccid paralysis of motor and autonomic nerves usually beginning with cranial nerves. </li>\r\n			<li>Paralysis begins with the cranial nerves, then affects the upper extremities, the respiratory muscles, and, finally, the lower extremities in a proximal-to-distal pattern.</li>\r\n			<li>In severe cases, extensive respiratory muscle paralysis leads to ventilatory failure and death unless supportive care is provided. </li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Found In</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>It is widely distributed and can be found in soil and water, on plants and in the gut of fish, birds and mammals.</li>\r\n			<li>Common foods that can be contaminated with C. botulinum include home-canned and bottled foods and vacuum-packed foods that have not been processed properly; fermented, salted and smoked meat and seafood; and (in the case of infant botulism) honey.</li>\r\n			<li>Commercially-processed foods are implicated as the source of a botulism events, including sausages, beef stew, canned vegetables, and seafood products.</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Hosts</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>Plants</li>\r\n			<li>Fish</li>\r\n			<li>Birds </li>\r\n			<li>Mammals</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Transmission</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Botulism is caused by ingestion of food contaminated by a preformed neurotoxin of the bacterium Clostridium botulinum. Home-preserved foods containing fish, vegetables, or potatoes are often involved in outbreaks of botulism. Home-prepared and home-preserved foods are the most frequent cause of poisoning. The use of modern plastic containers introduced a new risk factor in the ingestion of traditional food in the arctic regions. The particular foods involved vary according to geographical and cultural peculiarities:\r\n			<ul>\r\n				<li>Strong-smelling preserved bean curd in China.</li>\r\n				<li>Canned vegetables in U.S.A.</li>\r\n				<li>Meat from marine animals or fish/fish eggs fermented in traditional ways in Canada.</li>\r\n				<li>Preserved ham.</li>\r\n				<li>Home-made sauces; baked potatoes sealed in aluminum foil; cheese sauce; sautéed onions held under a layer of butter; garlic in oil; traditionally prepared salted or fermented fish.</li>\r\n			</ul>\r\n		</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Affected Organ</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Botulism is a paralyzing disease affecting the body\'s nervous system that is caused by the ingestion of one of the potent neurotoxins produced by C. botulinum bacterium. Botulism toxin causes flaccid paralysis by blocking motor nerve terminals at the myoneural junction. The paralysis progresses in a downward fashion, affecting the eyes and face, throat, chest and extremities and eventually causing respiratory paralysis and death.</p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Symptoms</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>Classic symptoms of botulism include:-</p>\r\n		<ul>\r\n			<li>Nausea, Vomiting, Vatigue, Dizziness, Double vision, Drooping eyelids, Slurred speech, Difficulty swallowing, Dryness of skin, Mouth, and Throat, Lack of fever, Muscle weakness, and Paralysis. </li>\r\n			<li>Infants with botulism appear lethargic, feed poorly, are constipated, and have a weak cry and poor muscle tone. Throughout all such symptoms, the victims are fully alert and the results of sensory examination are normal. </li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Inclubation Period</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>The symmetrical descending paralysis, when it occurs, usually appears 18 to 36 hours after exposure and generally lasts for 2 to 8 weeks. However, in severe cases, ventilatory support may be required for up to 7 months. </p>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Diagnosis</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<ul>\r\n			<li>The most direct and effective way to confirm the diagnosis of botulism in the laboratory is testing for the presence of the botulinum toxin in the serum, stool, or gastric secretions of the patient.</li>\r\n			<li>The food consumed by the patient can also be tested for the presence of toxins.</li>\r\n			<li>Nerve conduction studies (EMG), spinal fluid examinations and brain scans are helpful. </li>\r\n			<li>Recently, rapid, alternative, in-vitro procedures have been developed for the detection of types A, B, E, and F botulinal toxin producing organisms and their toxins. The toxins generated in culture media can be detected using ELISA techniques such as the DIG-ELISA and the amp-ELISA. The ELISA assays require one day of analysis. </li>\r\n			<li>The toxin genes of viable organisms can be detected using the polymerase chain reaction technique and require one days of analysis after overnight incubation of botulinal spores or vegetative cells. </li>\r\n			<li>In-vitro assays that are positive are confirmed using the mouse bioassay.</li>\r\n		</ul>\r\n	</span>\r\n	<span>\r\n		<span class=\"bold_action\">Prevention</span>\r\n		<hr align=\"right\" width=\"auto\">\r\n		<p>To prevent foodborne botulism:-</p>\r\n		<ul>\r\n			<li>Use approved heat processes for commercially and home-canned foods (i.e., pressure-can low-acid foods such as corn or green beans, meat, or poultry).</li>\r\n			<li>Discard all swollen, gassy, or spoiled canned foods. Double bag the cans or jars with plastic bags that are tightly closed. Then place the bags in a trash receptacle for non-recyclable trash outside the home. Keep it out of the reach of humans and pets.</li>\r\n			<li>Do not taste or eat foods from containers that are leaking, have bulges or are swollen, look damaged or cracked, or seem abnormal in appearance. Do not use products that spurt liquid or foam when the container is opened.</li>\r\n			<li>Boil home-processed, low-acid canned foods for 10 minutes prior to serving. For higher altitudes, add 1 minute for each 1,000 feet of elevation.</li>\r\n			<li>Refrigerate all leftovers and cooked foods within 2 hours after cooking (1 hour if the temperature is above 90 °F).</li>\r\n			<li>One of the most common causes of foodborne botulism is improperly home-canned food, especially low-acid foods such as vegetables and meats. Only a pressure cooker/canner allows water to reach 240 to 250 °F, a temperature that can kill the spores.</li>\r\n		</ul>\r\n		<span>\r\n			<span class=\"bold_action\">Treatment</span>\r\n			<hr align=\"right\" width=\"auto\">\r\n			<ul>\r\n				<li>If botulism is caught in the early stages, the injection of an antitoxin can lessen the severity of the disease by neutralizing any toxin that has not yet bound to nerve endings. One vial (7500 international units of type A, 5500 international units of type B and 8500 international units of type E antitoxins) equine antitoxin should be administered by infusion. </li>\r\n				<li>A human-derived antitoxin is used to treat cases of infant botulism. An ocular or cutaneous sensitivity test should be performed prior to administration of the equine antitoxin.</li>\r\n			</ul>\r\n		</span>\r\n		<div>\r\n			<span class=\"bold_action\">Taxonomic Classification</span>\r\n			<hr align=\"right\" width=\"auto\">\r\n			<table style=\"width:30%\">\r\n				<br>\r\n				<tr>\r\n					<th colspan=\"2\" style=\"text-align: center;\">Classification</th>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Kingdom</td>\r\n					<td>Bacteria</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Phylum</td>\r\n					<td>Firmicutes</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Class</td>\r\n					<td>Clostridia</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Order</td>\r\n					<td>Clostridiales</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Family</td>\r\n					<td>Clostridiaceae</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Genus</td>\r\n					<td>Clostridium</td>\r\n				</tr>\r\n				<tr>\r\n					<td class=\"Classification_heading\">Species</td>\r\n					<td>Botulinum</td>\r\n				</tr>		\r\n			</table>\r\n		</div>\r\n		<br>\r\n		<span>\r\n			<span class=\"bold_action\">Genome Information</span>\r\n			<hr align=\"right\" width=\"auto\">\r\n			<h4>Clostridium botulinum A str. ATCC 3502</h4>\r\n			<p><h4>Submitter:- <a class=\"sanger\" href=\"https://www.sanger.ac.uk/resources/downloads/bacteria/clostridium-botulinum.html\">Sanger Institute</a></h4></p>\r\n			<h4>Human Pathogen</h4>\r\n			<h4>Morphology</h4>\r\n			<ul class=\"mor\">\r\n					<li>Gram: Positive</li>\r\n					<li>Shape: Bacilli</li>\r\n					<li>Motility: Yes</li>\r\n			</ul>\r\n			<h4>Environment</h4>\r\n			<ul class=\"mor\">\r\n					<li>Salinity : NonHalophilic</li>\r\n					<li>OxygenReq: Anaerobic</li>\r\n					<li>OptimumTemperature: 37</li>\r\n					<li>TemperatureRange: Mesophilic</li>\r\n					<li>Habitat: Multiple</li>\r\n					<li>Phenotype = Disease: Botulism</li>\r\n			</ul>\r\n			<br>\r\n			<table>\r\n				<tr>\r\n					<th>Type</th>\r\n					<th>Name</th>\r\n					<th>RefSeq</th>\r\n					<th>INSDC</th>\r\n					<th>Size (Mb)</th>\r\n					<th>GC %</th>\r\n					<th>Protein</th>\r\n					<th>rRNA</th>\r\n					<th>tRNA</th>\r\n					<th>Other RNA</th>\r\n					<th>Gene</th>\r\n					<th>Pseudogene</th>\r\n				</tr>\r\n				<tr>\r\n					<td>Chr</td>\r\n					<td>-</td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/NC_009495.1\">NC_009495.1</a></td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/AM412317.1\">AM412317.1</a></td>\r\n					<td>3.89</td>\r\n					<td>28.2</td>\r\n					<td>3,563</td>\r\n					<td>27</td>\r\n					<td>80</td>\r\n					<td>7</td>\r\n					<td>3,767</td>\r\n					<td>81</td>\r\n				</tr>\r\n				<tr>\r\n					<td>Plsm</td>\r\n					<td>pBOT3502</td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/NC_009496.1\">NC_009496.1</a></td>\r\n					<td><a href=\"https://www.ncbi.nlm.nih.gov/nuccore/AM412318.1\">AM412318.1</a></td>\r\n					<td>0.02</td>\r\n					<td>26.8</td>\r\n					<td>18</td>\r\n					<td>-</td>\r\n					<td>-</td>\r\n					<td>-</td>\r\n					<td>19</td>\r\n					<td>1</td>\r\n				</tr>\r\n			</table>\r\n		</span>\r\n<br>\r\n		<span>\r\n			<span class=\"bold_action\">Reference</span>\r\n			<hr align=\"right\" width=\"auto\">\r\n			<ul class=\"refer\">\r\n				<li><a href=\"https://www.botulismblog.com/botulism-information-1/what-you-and-your-family-need-to-know-about-botulism/\">https://www.botulismblog.com/botulism-information-1/what-you-and-your-family-need-to-know-about-botulism/</a></li>\r\n				<li><a href=\"https://www.who.int/csr/delibepidemics/clostridiumbotulism.pdf\">https://www.who.int/csr/delibepidemics/clostridiumbotulism.pdf</a></li>\r\n				<li><a href=\"https://www.fsis.usda.gov/wps/portal/fsis/topics/food-safety-education/get-answers/food-safety-fact-sheets/foodborne-illness-and-disease/clostridium-botulinum/ct_index\">https://www.fsis.usda.gov/wps/portal/fsis/topics/food-safety-education/get-answers/food-safety-fact-sheets/foodborne-illness-and-disease/clostridium-botulinum/ct_index</a></li>\r\n				<li><a href=\"https://www.sciencedirect.com/topics/neuroscience/clostridium-botulinum\">https://www.sciencedirect.com/topics/neuroscience/clostridium-botulinum</a></li>\r\n				<li><a href=\"https://www.ehagroup.com/resources/pathogens/clostridium-botulinum-botulism/\">https://www.ehagroup.com/resources/pathogens/clostridium-botulinum-botulism/</a></li>\r\n				<li><a href=\"http://www.clinmed.rcpjournal.org/content/4/3/258.short\">http://www.clinmed.rcpjournal.org/content/4/3/258.short</a></li>\r\n				<li><a href=\"https://www.nejm.org/doi/pdf/10.1056/NEJM198607243150407\">https://www.nejm.org/doi/pdf/10.1056/NEJM198607243150407</a></li>\r\n				<li><a href=\"https://europepmc.org/abstract/med/15244052\">https://europepmc.org/abstract/med/15244052</a></li>\r\n				<li><a href=\"https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2672.2006.02987.x\">https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2672.2006.02987.x</a></li>\r\n				<li><a href=\"https://aem.asm.org/content/67/12/5694.short\">https://aem.asm.org/content/67/12/5694.short</a></li>\r\n				<li><a href=\"https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.20003\">https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.20003</a></li>\r\n				<li><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=clostridium%20botulism\">https://www.ncbi.nlm.nih.gov/pubmed/?term=clostridium%20botulism</a></li>\r\n				<li><a href=\"https://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1990.tb15461.x\">https://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1990.tb15461.x</a></li>\r\n				<li><a href=\"https://www.cabdirect.org/cabdirect/abstract/19642704287\">https://www.cabdirect.org/cabdirect/abstract/19642704287</a></li>\r\n				<li><a href=\"http://www.foodstandards.gov.au/consumer/safety/foodborne-illness/Pages/clostridium-botulinum.aspx\">http://www.foodstandards.gov.au/consumer/safety/foodborne-illness/Pages/clostridium-botulinum.aspx</a></li>\r\n				<li><a href=\"https://www.fda.gov/food/laboratory-methods-food/bam-clostridium-botulinum\">https://www.fda.gov/food/laboratory-methods-food/bam-clostridium-botulinum</a></li>\r\n			</ul>\r\n		</span>\r\n	</div>');

-- --------------------------------------------------------

--
-- Table structure for table `forum`
--

CREATE TABLE `forum` (
  `id` int(11) NOT NULL,
  `forum_question` longtext NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `forum`
--

INSERT INTO `forum` (`id`, `forum_question`) VALUES
(1, 'djchgijsijkdhjh'),
(3, 'dwsdsd'),
(4, 'dfdfddfdf'),
(5, 'fdfdfdfdfdfdf');

-- --------------------------------------------------------

--
-- Table structure for table `users`
--

CREATE TABLE `users` (
  `user_id` int(11) NOT NULL,
  `username` varchar(50) NOT NULL,
  `email` varchar(50) NOT NULL,
  `password` varchar(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `users`
--

INSERT INTO `users` (`user_id`, `username`, `email`, `password`) VALUES
(1, '', '', ''),
(2, 'sdfd', 'fdfdf', 'dfd'),
(3, 'piyush', 'piyush@piytsuh.coj', '78374'),
(4, 'abcd', 'sdskjdks@mdkfmd.com', '2323'),
(5, 'piyu', '', ''),
(6, '', '', ''),
(7, '1242', 'wewew', 'ewewe'),
(8, 'sd', 'sdsdss', 'dsds'),
(9, 'aman', 'vishwakarmaryan143@gmail.com', '123'),
(10, 'aman', 'vishwakarmaryan143@gmail.com', '123'),
(11, 'fdgdgd', 'gfdg', 'fdgd');

--
-- Indexes for dumped tables
--

--
-- Indexes for table `admin_login`
--
ALTER TABLE `admin_login`
  ADD PRIMARY KEY (`admin_id`);

--
-- Indexes for table `comment_table`
--
ALTER TABLE `comment_table`
  ADD PRIMARY KEY (`comment_id`);

--
-- Indexes for table `disease_caused`
--
ALTER TABLE `disease_caused`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `disease_data`
--
ALTER TABLE `disease_data`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `forum`
--
ALTER TABLE `forum`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `users`
--
ALTER TABLE `users`
  ADD PRIMARY KEY (`user_id`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `admin_login`
--
ALTER TABLE `admin_login`
  MODIFY `admin_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `comment_table`
--
ALTER TABLE `comment_table`
  MODIFY `comment_id` int(11) NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `disease_caused`
--
ALTER TABLE `disease_caused`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=10;

--
-- AUTO_INCREMENT for table `disease_data`
--
ALTER TABLE `disease_data`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=9;

--
-- AUTO_INCREMENT for table `forum`
--
ALTER TABLE `forum`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=6;

--
-- AUTO_INCREMENT for table `users`
--
ALTER TABLE `users`
  MODIFY `user_id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=12;
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
